Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
A licensed healthcare provider must determine if this combination is appropriate based on your medical history, current medications, and specific weight loss challenges
Molecular Characteristics Molecular Type: Synthetic growth hormone fragment research peptide Structure: Linear peptide chain Stability: High when stored under recommended laboratory conditions Molecular Weight: Sequence-dependent Molecular Stability and Storage Profile Supplied as a lyophilized powder for enhanced long-term stability Long-term storage: Store at 20C to preserve molecular integrity Sensitive to moisture and prolonged light exposure Predictable degradation above room temperature Reconstituted solutions remain stable for approximately 2448 hours under refrigeration Solubility and Reconstitution Characteristics Bacteriostatic water Sterile saline Acidic buffers Compatible analytical-grade organic solvents Technical Specifications product Name AOD9604 6mg cas 386264-39-7 purity 99% (HPLC verified) unit Size 6 mg vial form Lyophilized powder synthesis Solid-Phase Peptide Synthesis (SPPS) analytical HPLC, Mass Spectrometry, UV Spectrophotometry molecular Structure Linear peptide chain stability High when stored appropriately Analytical Validation and Quality Control High-Performance Liquid Chromatography (HPLC) purity confirmation Mass Spectrometry (MS) molecular identity and weight verification UV spectrophotometric concentration analysis Batch identity and consistency verification Endotoxin and microbial contamination screening Regulatory and Compliance Statement AOD9604 6mg is supplied strictly for laboratory research and scientific investigation
Reported and plausible concerns Finally, Nausea, flushing, headache, fatigue, yawning, and appetite changes Consequently, Spontaneous erections and possible priapism For example, Generalized darkening and changes in freckles or existing moles Moreover, Uncertain long-term melanocyte and melanoma-related risk In addition, Unknown cardiovascular, endocrine, reproductive, and drug-interaction effects However, Contamination or dosing variability in unregulated products Current evidence does not prove that Melanotan II directly causes melanoma
Research chemical vendors are not a recommended source regardless of price point or claimed purity
doi: 10.1002/ptr.4898
